Adaptive Phage Therapeutics Revenue

Biotechnology Research • Gaithersburg, Maryland, United States • 11-20 Employees

Adaptive Phage Therapeutics revenue & valuation

Annual revenue	$1,000,000
Revenue per employee	$72,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$3,200,000
Total funding	$12,000,000

Key Contact at Adaptive Phage Therapeutics

Mike Sowers

Director, Quality

Company overview

Headquarters	22 Firstfield Rd, 125, Gaithersburg, Maryland 20878, US
Phone number	+18449720500
Website	aphage.com
SIC	873
Founded	2016
Employees	11-20
Socials

Adaptive Phage Therapeutics Email Formats

Adaptive Phage Therapeutics uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@aphage.com), used 75% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@aphage.com	75%
{first name}{last name}	johndoe@aphage.com	25%

About Adaptive Phage Therapeutics

Adaptive Phage Therapeutics (APT) is a clinical-stage company advancing therapies addressing multi-drug resistant infections. Prior antimicrobial therapeutic approaches have been “fixed,” while pathogens continue to evolve resistance to each of those therapeutics, causing those drug products to become rapidly less effective in commercial use as antimicrobial resistance (AMR) increases over time. APT’s PhageBank™ approach leverages an ever-expanding library of bacteriophage (phage) that collectively provide evergreen broad spectrum and polymicrobial coverage. PhageBank™ phages are matched through a proprietary phage susceptibility assay that APT has teamed with Mayo Clinic Laboratories to commercialize on a global scale. APT’s technology was originally developed by the biodefense program of U.S. Department of Defense. APT acquired the world-wide exclusive commercial rights in 2017. Under FDA emergency Investigational New Drug allowance, APT has provided investigational PhageBank™ therapy to treat more than 40 critically ill patients in which standard-of-care antibiotics had failed.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Adaptive Phage Therapeutics has 9 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Adaptive Phage Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-07-09	5	$12,000,000

Funding Insights

$12,000,000

Total funding amount

$12,000,000

Most recent funding amount

Number of funding rounds

Adaptive Phage Therapeutics Tech Stack

Discover the technologies and tools that power Adaptive Phage Therapeutics's digital infrastructure, from frameworks to analytics platforms.

SiteGround

Hosting

Slick

JavaScript libraries

Microsoft 365

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

HTTP/3

Miscellaneous

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Bootstrap

UI frameworks

Yoast SEO

SEO

Frequently asked questions

Adaptive Phage Therapeutics is located in Gaithersburg, Maryland, US.

You can reach Adaptive Phage Therapeutics at +18449720500.

Adaptive Phage Therapeutics generates an estimated annual revenue of $1,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Adaptive Phage Therapeutics has an estimated valuation of $3,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Adaptive Phage Therapeutics was founded in 2016, making it 10 years old. The company has established itself as a significant player in its industry over this time.

Adaptive Phage Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Adaptive Phage Therapeutics has raised a total of $12,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Adaptive Phage Therapeutics

Mike Sowers

Director, Quality

4.8

40,000 users